LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Wojciech Nowak, Novartis, appointed as new Chair of EuropaBio’s Healthcare Council

    16/11/2023

    NEWS RELEASE

    Brussels, 16 November 2023 - EuropaBio is pleased to announce the appointment of Wojciech Nowak as the new Chair of its Healthcare Council. Mr. Nowak, currently serving as the Group Senior Director Global Governmental & Public Affairs at Novartis, has been elected by the council members and will assume the role of interim Chair until his official 2-year term commences in June 2024.

    Commenting on his appointment as Chair of the Healthcare Council, Wojciech Nowak said: “I am very pleased to take the role of Chair of the EuropaBio Healthcare Council, in this pivotal moment. I am looking forward to supporting the biotechnology industry in Europe to continue to be a leader in innovation, and to strengthen its life science sector. Let’s work together to establish an environment where innovation can flourish, and patients across Europe can access the medicines they need, when they need them.”

    Dr. Claire Skentelbery, Director General of EuropaBio added: “We are delighted to announce the appointment of Wojciech Nowak as the Chair of EuropaBio's Healthcare Council. Wojciech has a wealth of experience with Novartis, and a passion for the ecosystem in which Europe's biotechnology can flourish. He will play a key role in steering the Healthcare Council towards impactful initiatives at this most critical time for innovation within Europe's long-term ambitions. The team looks forward to working closely with him as we continue to advance biotechnology in the healthcare sector.”

    Wojciech Nowak, Novartis, appointed as new Chair of EuropaBio’s Healthcare Council


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more
    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Read more
    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives


    Read more

    Important links

    • OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States
    • Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.